Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
China Isotope & Radiation Corp. ( (HK:1763) ) has shared an announcement.
China Isotope & Radiation Corporation has announced its first export of self-produced irradiation equipment to the Latin American market, specifically to a Peruvian client for an Agricultural Gamma Irradiation Station Project. This project, aligned with the Belt and Road Initiative and the IAEA’s ‘Atoms for Food’ initiative, aims to improve the sterilization and shelf life of agricultural products, enhancing their market competitiveness. It also represents a step forward in China-Peru nuclear technology cooperation, potentially opening new global opportunities for China’s nuclear technology sector.
The most recent analyst rating on (HK:1763) stock is a Buy with a HK$25.00 price target. To see the full list of analyst forecasts on China Isotope & Radiation Corp. stock, see the HK:1763 Stock Forecast page.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation (CIRC) operates in the nuclear technology industry, focusing on the production and export of irradiation equipment. The company is involved in providing gamma irradiation devices and solutions, with a market focus on enhancing agricultural product quality and competitiveness.
Average Trading Volume: 353,873
Technical Sentiment Signal: Buy
Current Market Cap: HK$7.48B
Find detailed analytics on 1763 stock on TipRanks’ Stock Analysis page.